{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:59:20Z","timestamp":1789138760507,"version":"build-2803163510"},"reference-count":53,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>Adrenomedullin (AM) exerts strong pulmonary vasodilatory effects. These effects are mediated in part by nitric oxide. Plasma AM levels are increased in patients with pulmonary hypertension and correlate with disease severity and poor outcomes. Acute administration of AM improves the haemodynamics in patients with pulmonary hypertension, while chronic administration prevents the onset of pulmonary hypertension in animal models and delays its progression. Thus, AM is closely related to the pathophysiology of pulmonary hypertension and may be a promising therapeutic target.<\/jats:p>","DOI":"10.61409\/a07240498","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T06:31:36Z","timestamp":1736749896000},"page":"1-10","source":"Crossref","is-referenced-by-count":1,"title":["Adrenomedullin in pulmonary hypertension"],"prefix":"10.61409","author":[{"given":"Toshio","family":"Nishikimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Inazumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2024,12,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Baliga RS, Macallister RJ, Hobbs AJ. Vasoactive peptides and the pathogenesis of the pulmonary and hypertension: role and potential therapeutic application. Handb Exp Pharmacol. 2013;218:477-511. https:\/\/doi.org\/10.1007\/978-3-642-38664-0_19","DOI":"10.1007\/978-3-642-38664-0_19"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192(2):553-60. https:\/\/doi: 10.1006\/bbrc.1993.1451.","DOI":"10.1006\/bbrc.1993.1451"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Sugo S, Minamino N, Kangawa K et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201(3):1160-6. https:\/\/doi.org\/10.1006\/bbrc.1994.1827","DOI":"10.1006\/bbrc.1994.1827"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Sugo S, Minamino N, Shoji H et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 1994;203(1):719-26. https:\/\/doi.org\/10.1006\/bbrc.1994.2241","DOI":"10.1006\/bbrc.1994.2241"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"McLatchie LM, Fraser NJ, Main MJ et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998;393(6683):333-9. https:\/\/doi.org\/10.1038\/30666","DOI":"10.1038\/30666"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Harel F, Levac X, Nguyen QT et al. Molecular imaging of the human pulmonary vascular endothelium usinga adrenomedullin receptor ligand. Mol Imaging. 2015:14. https:\/\/doi.org\/10.2310\/7290.2015.00003","DOI":"10.2310\/7290.2015.00003"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Horio T, Kohno M, Kano H et al. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res. 1995;77(4):660-4. https:\/\/doi.org\/10.1161\/01.res.77.4.660","DOI":"10.1161\/01.RES.77.4.660"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Kano H, Kohno M, Yasunari K et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens. 1996;14(2):209-13. https:\/\/doi.org\/10.1097\/00004872-199602000-00009","DOI":"10.1097\/00004872-199602000-00009"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Upton PD, Wharton J, Coppock H et al. Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations. Am J Respir Cell Mol Biol. 2001;24(2):170-8. https:\/\/doi.org\/10.1165\/ajrcmb.24.2.4210","DOI":"10.1165\/ajrcmb.24.2.4210"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Nishikimi T, Tadokoro K, Akimoto K et al. Response of adrenomedullin system to cytokine in cardiac fibroblasts-role of adrenomedullin as an antifibrotic factor. Cardiovasc Res. 2005;66(1):104-13. https:\/\/doi.org\/10.1016\/j.cardiores.2004.12.015","DOI":"10.1016\/j.cardiores.2004.12.015"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zhou PH, Hu W, Zhang XB et al. Protective effect of adrenomedullin on rat Leydig cells from lipopolysaccharide-induced inflammation and apoptosis via the PI3K\/Akt signaling pathway ADM on rat Leydig cells from inflammation and apoptosis. Mediators Inflamm. 2016;2016:7201549. https:\/\/doi.org\/10.1155\/2016\/7201549","DOI":"10.1155\/2016\/7201549"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Hu W, Shi L, Li MY et al. Adrenomedullin protects Leydig cells against lipopolysaccharide-induced oxidative stress and inflammatory reaction via MAPK\/NF-\u03baB signalling pathways. Sci Rep. 2017;7(1):16479. https:\/\/doi.org\/10.1038\/s41598-017-16008-x","DOI":"10.1038\/s41598-017-16008-x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Cheng DY, DeWitt BJ, Wegmann MJ et al. Synthetic human adrenomedullin and ADM15-52 have potent short-lasting vasodilator activity in the pulmonary vascular bed of the cat. Life Sci. 1994;55(14):PL251-6. https:\/\/doi.org\/10.1016\/0024-3205(94)00246-0","DOI":"10.1016\/0024-3205(94)00246-0"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"DeWitt BJ, Cheng DY, Caminiti GN et al. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur J Pharmacol. 1994;257(3):303-6. https:\/\/doi.org\/10.1016\/0014-2999(94)90143-0","DOI":"10.1016\/0014-2999(94)90143-0"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Heaton J, Lin B, Chang JK et al. Pulmonary vasodilation to adrenomedullin: a novel peptide in humans. Am J Physiol. 1995;268(6 pt 2):H2211-5. https:\/\/doi.org\/10.1152\/ajpheart.1995.268.6.H2211","DOI":"10.1152\/ajpheart.1995.268.6.H2211"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Nossaman BD, Feng CJ, Cheng DY et al. Comparative effects of adrenomedullin, an adrenomedullin analog, and CGRP in the pulmonary vascular bed of the cat and rat. Life Sci. 1995;56(3):PL63-6.","DOI":"10.1016\/0024-3205(94)00899-X"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Nossaman BD, Feng CJ, Kaye AD et al. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am J Physiol. 1996;270(5 pt 1):L782-9. https:\/\/doi.org\/10.1152\/ajplung.1996.270.5.L782","DOI":"10.1152\/ajplung.1996.270.5.L782"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Shirai M, Shimouchi A, Ikeda S et al. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats. Br J Pharmacol. 1997;121(4):679-86. https:\/\/doi.org\/10.1038\/sj.bjp.0701178","DOI":"10.1038\/sj.bjp.0701178"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Yang BC, Lippton H, Gumusel B et al. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol. 1996;28(3):458-62. https:\/\/doi.org\/10.1097\/00005344-199609000-00016","DOI":"10.1097\/00005344-199609000-00016"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Zhao L, Brown LA, Owji AA et al. Adrenomedullin activity in chronically hypoxic rat lungs. Am J Physiol. 1996;271(2 pt 2):H622-9. https:\/\/doi.org\/10.1152\/ajpheart.1996.271.2.H622","DOI":"10.1152\/ajpheart.1996.271.2.H622"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Roh J, Chang CL, Bhalla A et al. Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes. J Biol Chem. 2004;279(8):7264-74. https:\/\/doi.org\/10.1074\/jbc.M305332200.","DOI":"10.1074\/jbc.M305332200"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kandilci HB, Gumusel B, Wasserman A et al. Intermedin\/adrenomedullin-2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides. 2006;27(6):1390-6. https:\/\/doi.org\/10.1016\/j.peptides.2005.10.024.","DOI":"10.1016\/j.peptides.2005.10.024"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Telli G, Tel BC, Yersal N et al. Effect of intermedin\/adrenomedullin2 on the pulmonary vascular bed in hypoxia-induced pulmonary hypertensive rats. Life Sci. 2018;192:62-7. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.031","DOI":"10.1016\/j.lfs.2017.11.031"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ishimitsu T, Kojima M, Kangawa K et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun. 1994;203(1):631-9. https:\/\/doi.org\/10.1006\/bbrc.1994.2229","DOI":"10.1006\/bbrc.1994.2229"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Nishikimi T, Nakagawa Y. Adrenomedullin as a biomarker of heart failure. Heart Fail Clin. 2018;14(1):49-55. https:\/\/doi.org\/10.1016\/j.hfc.2017.08.006","DOI":"10.1016\/j.hfc.2017.08.006"},{"issue":"3","key":"ref25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/clinchem\/44.3.571","article-title":"Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage","volume":"44","author":"Lewis","year":"1998","unstructured":"Lewis LK, Smith MW, Yandle TG et al. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem. 1998;44(3):571-7.","journal-title":"Clin Chem"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005;51(10):1823-9. https:\/\/doi.org\/10.1373\/clinchem.2005.051110","DOI":"10.1373\/clinchem.2005.051110"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Nishikimi T, Horio T, Kohmoto Y et al. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J Hypertens. 2001;19(4):765-73. https:\/\/doi.org\/10.1097\/00004872-200104000-00014","DOI":"10.1097\/00004872-200104000-00014"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Nishikimi T, Matsuoka H, Shimada K et al. Production and clearance sites of two molecular forms of adrenomedullin in human plasma. Am J Hypertens. 2000;13(9):1032-4. https:\/\/doi.org\/10.1016\/s0895-7061(00)00254-5","DOI":"10.1016\/S0895-7061(00)00254-5"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Nishikimi T, Tadokoro K, Mori Y et al. Ventricular adrenomedullin system in the transition from LVH to heart failure in rats. Hypertension. 2003;41(3):512-8. https:\/\/doi.org\/10.1161\/01.HYP.0000053447.64213.C4","DOI":"10.1161\/01.HYP.0000053447.64213.C4"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Shimokubo T, Sakata J, Kitamura K et al. Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci. 1995;57(19):1771-9. https:\/\/doi.org\/10.1016\/0024-3205(95)02155-c","DOI":"10.1016\/0024-3205(95)02155-C"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Nakanishi K, Osada H, Uenoyama M et al. Expressions of adrenomedullin mRNA and protein in rats with hypobarichypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2004;286(6):H2159-68. https:\/\/doi.org\/10.1152\/ajpheart.00846.2003","DOI":"10.1152\/ajpheart.00846.2003"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Nishikimi T, Nagata S, Sasaki T et al. Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart. 1997;78(4):390-5. https:\/\/doi.org\/10.1136\/hrt.78.4.390","DOI":"10.1136\/hrt.78.4.390"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/cs0960033","article-title":"Increased plasma levels of adrenomedullin in patients with pulmonary hypertension","volume":"96","author":"Kakishita","year":"1999","unstructured":"Kakishita M, Nishikimi T, Okano Y et al. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci (Lond). 1999;96(1):33-9.","journal-title":"Clin Sci (Lond)"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Yoshibayashi M, Kamiya T, Kitamura K et al. Plasma levels of adrenomedullin in primary and secondary pulmonaryhypertension in patients <20 years of age. Am J Cardiol. 1997;79(11):1556-8. https:\/\/doi.org\/10.1016\/s0002-9149(97)00195-1","DOI":"10.1016\/S0002-9149(97)00195-1"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Bouzina H, R\u00e5degran G. Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification. Pulm Circ. 2020;10(3):2045894020931317. https:\/\/doi.org\/10.1177\/2045894020931317","DOI":"10.1177\/2045894020931317"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Elesawy SA, El-Serogy HA, Sorour EA, Zoair AM. Plasma mid-regional proadrenomedullin level in children. Cardiol Young. 2023;33(12):2567-73. https:\/\/doi.org\/10.1017\/S1047951123000471","DOI":"10.1017\/S1047951123000471"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Yoshihara F, Nishikimi T, Horio T et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol. 1998;355(1):33-9. https:\/\/doi.org\/10.1016\/s0014-2999(98)00475-0","DOI":"10.1016\/S0014-2999(98)00475-0"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Qi JG, Ding YG, Tang CS, Du JB. Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats. Peptides. 2007;28(4):910-9. https:\/\/doi.org\/10.1016\/j.peptides.2006.12.008","DOI":"10.1016\/j.peptides.2006.12.008"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Hoeper MM, Schwarze M, Ehlerding S et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med. 2000;342(25):1866-70. https:\/\/doi.org\/10.1056\/NEJM200006223422503","DOI":"10.1056\/NEJM200006223422503"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Kandler MA, Von Der Hardt K, Mahfoud S et al. Pilot intervention: aerosolized adrenomedullin reduces pulmonary hypertension. Pharmacol Exp Ther. 2003;306(3):1021-6. https:\/\/doi.org\/10.1124\/jpet.103.049817","DOI":"10.1124\/jpet.103.049817"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Nagaya N, Okumura H, Uematsu M et al. Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats. Am J Physiol Heart Circ Physiol. 2003;285(5):H2125-31. https:\/\/doi.org\/10.1152\/ajpheart.00548.2002","DOI":"10.1152\/ajpheart.00548.2002"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Champion HC, Bivalacqua TJ, Toyoda K et al. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation. 2000;101(8):923-30. https:\/\/doi.org\/10.1161\/01.cir.101.8.923","DOI":"10.1161\/01.CIR.101.8.923"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Harada-Shiba M, Takamisawa I, Miyata K et al. Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in rats. Mol Ther. 2009;17(7):1180-6. https:\/\/doi.org\/10.1038\/mt.2009.63","DOI":"10.1038\/mt.2009.63"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Matsui H, Shimosawa T, Itakura K et al. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia. Circulation. 2004;109(18):2246-51. https:\/\/doi.org\/10.1161\/01.CIR.0000127950.13380.FD","DOI":"10.1161\/01.CIR.0000127950.13380.FD"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Holmes D, Corr M, Thomas G et al. Protective effects of intermedin\/adrenomedullin-2 in a cellular model of human pulmonary arterial hypertension. Peptides. 2020;126:170267. https:\/\/doi.org\/10.1016\/j.peptides.2020.170267","DOI":"10.1016\/j.peptides.2020.170267"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Nagaya N, Nishikimi T, Uematsu M et al. Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart. 2000;84(6):653-8. https:\/\/doi.org\/10.1136\/heart.84.6.653","DOI":"10.1136\/heart.84.6.653"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Nagaya N, Kyotani S, Uematsu M et al. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation. 2004;109(3):351-6. https:\/\/doi.org\/10.1161\/01.CIR.0000109493.05849.14","DOI":"10.1161\/01.CIR.0000109493.05849.14"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Yoshimoto T, Saito S, Omae K et al. Study protocol for a randomized, double-blind, placebo-controlled, phase-II trial: adrenomedullin for ischemic stroke study. J Stroke Cerebrovasc Dis. 2021;30(6):105761. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.10576","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105761"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Kita T, Ashizuka S, Ohmiya N et al. Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial. J Gastroenterol. 2021;56(2):147-57. https:\/\/doi.org\/10.1007\/s00535-020-01741-4","DOI":"10.1007\/s00535-020-01741-4"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Kita T, Ashizuka S, Takeda T et al. Adrenomedullin for biologic-resistant Crohn's disease: a randomized, double-blind, placebo-controlled phase 2a clinical trial. J Gastroenterol Hepatol. 2022;37(11):2051-9. https:\/\/doi.org\/10.1111\/jgh.15945","DOI":"10.1111\/jgh.15945"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Washida K, Saito S, Tanaka T et al. A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Cereb Circ Cogn Behav. 2024;6:100211. https:\/\/doi.org\/10.1016\/j.cccb.2024.100211","DOI":"10.1016\/j.cccb.2024.100211"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Akashi E, Nagata S, Yamasaki M, Kitamura K. Activation of calcitonin gene-related peptide and adrenomedullin receptors by PEGylated adrenomedullin. Biol Pharm Bull. 2020;43(11):1799-803. https:\/\/doi.org\/10.1248\/bpb.b20-00373","DOI":"10.1248\/bpb.b20-00373"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:41:47Z","timestamp":1753692107000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A07240498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":53,"URL":"https:\/\/doi.org\/10.61409\/a07240498","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}